All In MedTech

Device Trial Radar · NCT06773013

Safety and Effectiveness of Sonu for Pediatric Nasal Congestion

Safety and Effectiveness of Sonu Acoustic Resonance Therapy for the Treatment of Pediatric Patients With Moderate to Severe Nasal Congestion.

Last checked: Nov 19, 2026Latest source record: Sep 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

31

Actual

Start

Jan 9, 2025

Primary completion

Mar 16, 2025

Study completion Mar 30, 2025

Sponsor

Lead sponsor
Third Wave TherapeuticsNot on our public-company list
Sponsor type
Industry
First posted
Jan 14, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 12 years, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.

Conditions

  • Nasal Congestion and Inflammations

Interventions

  • Acoustic Resonance (Sound) TherapyDevice

    Sonu consists of an acoustic Vibrational Headband worn circumferentially at the level of the forehead; and a Smartphone App, paired to the Headband. The App determines acoustic resonant frequencies of the subject's nasal cavity (using the facial image) and delivers treatment through bone conduction transducers in the headband

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serious adverse eventsTime frame: 2 weeks
  2. Reduction in nasal congestion subscoreTime frame: 2 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Crescendo MD

    Portola Valley, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.